Stem-cell patent battle continues

April 28, 2011 by Deborah Braconnier, report
Scientists say ‘No’ to a ban on stem cell patents recommended by the European Court of Justice

( -- A group of 13 of the top stem-cell research scientists submitted a letter to the journal Nature this week in response to the European Court of Justice (ECJ) case that could ban all patents involving stem-cell based therapies in Europe.

This battle has been ongoing since 1999 when the international organization Greenpeace put forth a challenge on a patent by Oliver Brustle of the University of Bonn. They argued that his patent for neural that were derived from available human (hESCs) violated the 1973 European Patent Convention by being immoral. The ECJ is required to reach a decision in the upcoming weeks.

What currently has scientists on edge is a statement made on March 10 by the courts advocate general Yves Bot where he essentially backed the Greenpeace challenge. The courts have a history of backing some 80 percent of the cases in which he has put forth a recommendation.

Bot argues that while hESCs are able to be purified and can be multiplied for researchers indefinitely, they were originally taken from that were destroyed. Because all of hESCs are a result of embryo destruction, they violate the European patent directive of 1998 that prohibits the use of embryos for commercial and industrial purposes.

Should the courts decide to block patents involving hESCs it would stop all current research of stem cell treatments in Europe. Scientists like professor Pete Coffey of the London Project to Cure Blindness who is currently working on stem cell research to restore sight argues that there is an ethical need to treat disease and that is what this research is providing. The 13 scientists also are upset with the implication that the research they are conducting is immoral, as the research they are performing has the potential to relieve suffering and treat or cure many conditions and diseases.

Without these patents, the scientists would lose research funding by the pharmaceutical companies who will not be willing to risk their investment without the protection of a . If this ban is passed, scientists may have to move their research to another country such as China, Japan, or U.S. where patents are allowed.

Explore further: U.S. rejects three stem cell patents

More information: 'No' to ban on stem-cell patents, Nature 472, 418 (28 April 2011) doi:10.1038/472418a

The advocate-general of the European Court of Justice has recommended the prohibition on ethical grounds of patents involving human embryonic stem cells (Nature 471, 280; 2011). We write to express profound concern over this recommendation, as coordinators of multinational European stem-cell projects, working with both adult and embryonic stem cells. Embryonic stem cells are cell lines, not embryos. They are derived using surplus in vitro fertilized eggs donated after fertility treatment and can be maintained indefinitely. As more than 100 established lines are now supplied through national and international cell banks, concern about commercialization of the human embryo is misplaced.

The letter plus comments from ethicists and scientists is available on, along with the opportunity to comment or add a signature at

Related Stories

U.S. rejects three stem cell patents

April 4, 2007

The U.S. Patent and Trademark Office has issued a preliminary rejection of three stem cell patents held by the University of Wisconsin-Madison.

EU revises position on software patents

June 5, 2006

Is software patentable in Europe? Following questioning from a member of the European parliament, the European Commission recently released a statement containing strong implications that computer programs aren't patentable, ...

European office withdraws Nexium patent

December 21, 2006

The European Patent Office, answering a generic drug maker's challenge, withdrew a patent on Britain-based AstraZeneca PLC's heartburn treatment, Nexium.

House bill funds embryonic stem cell study

January 10, 2007

As the U.S. House seeks to expand embryonic stem cell research funding, the White House is promoting stem cell development methods that don't harm embryos.

Recommended for you

Cells lacking nuclei struggle to move in 3-D environments

January 20, 2018

University of North Carolina Lineberger Comprehensive Cancer Center researchers have revealed new details of how the physical properties of the nucleus influence how cells can move around different environments - such as ...

Microbial communities demonstrate high turnover

January 19, 2018

When Mark Twain famously said "If you don't like the weather in New England, just wait a few minutes," he probably didn't anticipate MIT researchers would apply his remark to their microbial research. But a new study does ...

Hot weather is bad news for bird sperm

January 19, 2018

A new study led by Macquarie University and spanning Sydney and Oslo has shown that exposure to extreme temperatures, such as those experienced during heatwave conditions, significantly reduces sperm quality in zebra finches, ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Apr 28, 2011
again more with this patenting of things that exist naturally in my body, first my dna, now this, what's next a lawsuit for breaching your patent on my body? I will resist with every thread of my being the morally bankrupt will now pay, the canadian tobacco movement is going to be starting this summer, the poor are going to break free from their bondage to this system starting with the economic desperation back breaking taxes on tobacco have produced. Every smoker in canada could pay the national debt off in under 5 years,so where is all that money going that our governments are stealing from us? We get to suffer no opportunity just for wanting a smoke? There are ways around that and this system's smoke money is going to dry up and I'll go out of my way to hook people up with a gift just to hit the system in the pocket book where it hurts. THIS IS EVIL. Any system that goes along with this patent travesty must be brought down for our own good.
5 / 5 (1) Apr 29, 2011
Foolish people think economics don't matter. If someone expends a bunch of money to find that one person who's genetic mutation cures my disease, dang straight I'm going to support their effort to make money and continue their search for more cures.

As with anything humans do, there are pitfalls. But to hide in a closet and curse the dark is cowardly and modern society didn't become the wonder it is today being cowardly.
not rated yet Apr 29, 2011
Smoking anything you want, like setting fire to yourself, should not be illegal; but I do have the right to not have to smell your stink.
not rated yet Apr 30, 2011
I'd rather accept the patent risks if its the only means of advancement. If the slippery slope actually happens, it will eventually reach a point of absurdity which would result in reforms. (As long as the government is still honest and not bought out)

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.